Does HUMAN IMMUNOGLOBULIN G Cause Therapy cessation? 219 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Therapy cessation have been filed in association with HUMAN IMMUNOGLOBULIN G (BIVIGAM). This represents 0.3% of all adverse event reports for HUMAN IMMUNOGLOBULIN G.
219
Reports of Therapy cessation with HUMAN IMMUNOGLOBULIN G
0.3%
of all HUMAN IMMUNOGLOBULIN G reports
6
Deaths
69
Hospitalizations
How Dangerous Is Therapy cessation From HUMAN IMMUNOGLOBULIN G?
Of the 219 reports, 6 (2.7%) resulted in death, 69 (31.5%) required hospitalization, and 5 (2.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN IMMUNOGLOBULIN G Cause?
Headache (7,885)
Off label use (5,872)
Fatigue (5,423)
Nausea (4,454)
Sinusitis (4,409)
Pyrexia (4,076)
Drug ineffective (3,923)
Pruritus (3,775)
Dyspnoea (3,518)
Malaise (3,180)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which HUMAN IMMUNOGLOBULIN G Alternatives Have Lower Therapy cessation Risk?
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN IMMUNOGLOBULIN G vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMAN IMMUNOGLOBULIN G vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G vs HUMAN RHO IMMUNE GLOBULIN